Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	290	507	411	107	125	255
Market Cap Growth	-55.90%	23.47%	282.96%	-14.41%	-50.83%	-14.22%
Enterprise Value	229.09	444.01	367.62	82.47	108.39	230.73
Last Close Price	3.63	6.36	5.31	1.43	1.68	3.74
PE Ratio	17.47	31.80	48.27	-	-	-
Forward PE	17.59	27.81	50.28	-	-	-
PS Ratio	2.25	3.92	4.12	1.28	1.74	3.78
PB Ratio	3.55	6.62	8.91	3.77	4.37	8.03
P/TBV Ratio	3.77	7.10	9.00	3.77	4.09	7.92
P/FCF Ratio	71.34	38.37	34.37	15.39	-	-
P/OCF Ratio	66.16	37.54	33.91	15.07	-	-
EV/Sales Ratio	1.76	3.43	3.69	0.99	1.50	3.42
EV/EBITDA Ratio	19.12	33.90	43.05	-	-	-
EV/EBIT Ratio	20.64	36.06	47.58	-	-	-
EV/FCF Ratio	55.79	33.61	30.77	11.83	-	-
Debt / Equity Ratio	0.02	0.02	0.04	0.09	0.12	0.13
Debt / EBITDA Ratio	0.22	0.22	0.31	-	-	-
Debt / FCF Ratio	0.63	0.21	0.22	0.47	-	-
Net Debt / Equity Ratio	-0.78	-0.81	-0.91	-0.84	-0.56	-0.74
Net Debt / EBITDA Ratio	-5.34	-4.73	-4.92	5.26	0.92	0.91
Net Debt / FCF Ratio	-15.58	-4.69	-3.52	-3.45	1.05	0.96
Asset Turnover	1.18	1.48	1.62	1.53	1.29	1.40
Inventory Turnover	2.10	3.12	3.21	2.25	2.07	2.05
Quick Ratio	3.49	3.74	2.92	1.58	1.62	1.90
Current Ratio	4.61	4.86	3.57	2.40	2.61	2.78
Return on Equity (ROE)	21.24%	25.00%	25.97%	-17.29%	-54.77%	-112.68%
Return on Assets (ROA)	9.46%	13.39%	12.15%	-10.27%	-33.29%	-56.29%
Return on Invested Capital (ROIC)	41.79%	77.00%	98.62%	-45.68%	-127.08%	-288.01%
Return on Capital Employed (ROCE)	12.47%	18.00%	18.25%	-15.88%	-48.75%	-87.18%
Earnings Yield	6.36%	3.14%	2.07%	-	-	-
FCF Yield	1.40%	2.61%	2.91%	6.50%	-	-
Buyback Yield / Dilution	-7.04%	-9.36%	-4.19%	-7.54%	-3.79%	-10.02%
Total Shareholder Return	-7.04%	-9.36%	-4.19%	-7.54%	-3.79%	-10.02%

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q